Opioid use disorder (OUD) is a medical condition that can affect anyone – regardless of race, gender, income level or social class. Learn organizational best practices and compare naloxone nasal spray against naloxone intramuscular injection (IM).
Important Update: Telligen’s 12th SOW QIN-QIO contract extension concludes March 7, 2025. Stay tuned for future program updates at telligenqiconnect.com.